Sanofi (SNYNF) stock
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Sanofi operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was €6.34B, down 12.5% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is €14.11B in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €6.34B | -12.5% |
| FY2024 | Dec 31, 2024 | €7.25B | +4.2% |
| FY2023 | Dec 31, 2023 | €6.96B | -31.5% |
| FY2022 | Dec 31, 2022 | €10.16B | +25.1% |
| FY2021 | Dec 31, 2021 | €8.13B | -42.4% |
| FY2020 | Dec 31, 2020 | €14.11B | +362.6% |
| FY2019 | Dec 31, 2019 | €3.05B | -34.8% |
| FY2018 | Dec 31, 2018 | €4.68B | -19.4% |
| FY2017 | Dec 31, 2017 | €5.80B | -11.1% |
| FY2016 | Dec 31, 2016 | €6.53B | +16.1% |
| FY2015 | Dec 31, 2015 | €5.62B | – |
See a number that looks wrong?